A Randomized, Double-Blind Study to Assess the Efficacy and Safety of Valtropin, a Biosimilar Growth Hormone, in Children with Growth Hormone Deficiency-Reference-Cited by-同舟云学术

A Randomized, Double-Blind Study to Assess the Efficacy and Safety of Valtropin, a Biosimilar Growth Hormone, in Children with Growth Hormone Deficiency

Published:2007 Issue:6 Volume:68 Page:288-293
ISSN:1663-2818
Container-title:Hormone Research in Paediatrics
language:en
Short-container-title:Horm Res Paediatr

Author:

Peterkova Valentina,Arslanoglu Ilknur,Bolshova-Zubkovskaya Elena,Romer Tomasz,Zdravkovic Dragan,Kratzsch Jürgen,Ji Hyi-Jeong,Savoy Conrad,Saenger Paul

Publisher

S. Karger AG

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology and Child Health

Reference24 articles.

1. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Growth Hormone Use in Adults and Children—2003 Update

2. Consensus Guidelines for the Diagnosis and Treatment of Growth Hormone (GH) Deficiency in Childhood and Adolescence: Summary Statement of the GH Research Society

3. Guidelines for the use of growth hormone in children with short stature A report by the Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Societya

4. Update of guidelines for the use of growth hormone in children: the Lawson Wilkins pediatric endocrinology society drug and therapeutics committee

5. Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substance. Committee for Medicinal Products for Human Use (CHMP), European Medicine Agency (EMEA), CHMP/437, 2004.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Short-term efficacy and safety of a lower dose of polyethylene glycol recombinant human growth hormone in children with growth hormone deficiency: A randomized, dose-comparison study;Frontiers in Pharmacology;2022-08-11

2. Safety and Efficacy of Lonapegsomatropin in Children With Growth Hormone Deficiency: enliGHten Trial 2-Year Results;The Journal of Clinical Endocrinology & Metabolism;2022-04-16

3. An Introduction to Biosimilars for the Treatment of Retinal Diseases: A Narrative Review;Ophthalmology and Therapy;2022-03-12

4. Switching from originator recombinant growth hormone (Genotropin™) to biosimilar (CRISCY™): Results from a 6-month, multicentric, non-inferiority, extension trial.;Growth Hormone & IGF Research;2021-02

5. Efficacy and safety of a biosimilar recombinant human growth hormone (r-hGH Cristalia) compared with reference r-hGH in children with growth hormone deficiency (CERES study): A randomized, multicentric, investigator-blind, phase 3 trial;Growth Hormone & IGF Research;2019-10